Andreka P. Cytoprotection by Jun kinase during nitric oxide-induced cardiac myocyte apoptosis. (2001) CIRCULATION RESEARCH 0009-7330 1524-4571 88 3 305-312,
2875578
Chen W et al. Follistatin-like 1 protects cardiomyoblasts from injury induced by sodium nitroprusside through modulating Akt and Smad1/5/9 signaling. (2016) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 469 3 418-423
Fan Ming-Jen. Reduction of TLR4 mRNA Stability and Protein Expressions through Inhibiting Cytoplasmic Translocation of HuR Transcription Factor by E-2 and/or ER alpha in LPS-Treated H9c2 Cardiomyoblast Cells. (2014) CHINESE JOURNAL OF PHYSIOLOGY 0304-4920 57 1 8-18
Kim Seok et al. Epigallocatechin-3-gallate, a green tea catechin, protects the heart against regional ischemia-reperfusion injuries through activation of RISK survival pathways in rats. (2014) ARCHIVES OF PHARMACAL RESEARCH 0253-6269 37 8 1079-1085
Javadov Sabzali et al. Crosstalk between mitogen-activated protein kinases and mitochondria in cardiac diseases: Therapeutic perspectives. (2014) PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X 144 2 202-225
Marongiu E et al. Cardioprotection acquired through exercise: The role of ischemic preconditioning. (2014) CURRENT CARDIOLOGY REVIEWS 1573-403X 1875-6557 10 4 336-348
Chen Jian et al. A New Synthetic Ursolic Acid Derivative IUA with Anti-Tumor Efficacy Against Osteosarcoma Cells via Inhibition of JNK Signaling Pathway. (2014) CELLULAR PHYSIOLOGY AND BIOCHEMISTRY 1015-8987 1421-9778 34 3 724-733
Jiang Surong et al. alpha-Lipoic acid protected cardiomyoblasts from the injury induced by sodium nitroprusside through ROS-mediated Akt/Gsk-3 beta activation. (2014) TOXICOLOGY IN VITRO 0887-2333 1879-3177 28 8 1461-1473
Hochhauser Edith et al. P2Y(2) receptor agonist with enhanced stability protects the heart from ischemic damage in vitro and in vivo. (2013) PURINERGIC SIGNALLING 1573-9538 1573-9546 9 4 633-642
Yang Cheng-Hsu et al. Effect of Tacrolimus on Myocardial Infarction Is Associated with Inflammation, ROS, MAP Kinase and Akt Pathways in Mini-Pigs. (2013) JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS 1340-3478 1880-3873 20 1 9-22
Carnovale Cristina et al. Role of nitric oxide in liver regeneration. (2012) ANNALS OF HEPATOLOGY - OFFICIAL JOURNAL OF THE MEXICAN ASSOCIATION OF HEPATOLOGY 1665-2681 11 5 636-647
Lv Xiao et al. Resveratrol protects H9c2 embryonic rat heart derived cells from oxidative stress by inducing autophagy: role of p38 mitogen-activated protein kinase. (2012) CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 0008-4212 1205-7541 90 5 655-662
Blanton Robert et al. Protein Kinase G I alpha Inhibits Pressure Overload-Induced Cardiac Remodeling and Is Required for the Cardioprotective Effect of Sildenafil In Vivo. (2012) JOURNAL OF THE AMERICAN HEART ASSOCIATION 2047-9980 2047-9980 1 5
Vainio L et al. Neuronostatin, a novel peptide encoded by somatostatin gene, regulates cardiac contractile function and cardiomyocyte survival. (2012) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 287 7 4572-4580
Ahn Jihyun et al. Mechanisms and Consequences of Inflammatory Signaling in the Myocardium. (2012) CURRENT HYPERTENSION REPORTS 1522-6417 1534-3111 14 6 510-516
Yang Junjie et al. Human adipose tissue-derived stem cells protect impaired cardiomyocytes from hypoxia/reoxygenation injury through hypoxia-induced paracrine mechanism. (2012) CELL BIOCHEMISTRY AND FUNCTION 0263-6484 1099-0844 30 6 505-514
Stulpinas Aurimas et al. Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells. (2012) CELL BIOLOGY AND TOXICOLOGY 0742-2091 1573-6822 28 2 103-114
Gray Warren et al. N-acetylglucosamine Conjugated to Nanoparticles Enhances Myocyte Uptake and Improves Delivery of a Small Molecule p38 Inhibitor for Post-infarct Healing. (2011) JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH 1937-5387 1937-5395 4 5 631-643
White Phillip et al. Nitrosative modifications of protein and lipid signaling molecules by reactive nitrogen species. (2010) AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM 0193-1849 1522-1555 299 6 E868-E878
Rose Beth A et al. Mitogen-Activated Protein Kinase Signaling in the Heart: Angels Versus Demons in a Heart-Breaking Tale. (2010) PHYSIOLOGICAL REVIEWS 0031-9333 1522-1210 90 4 1507-1546
Ryazanceva NV. The role of redox-dependent signal systems in the regulation of apoptosis under oxidative stress condition. (2009) CITOLOGIJA 0041-3771 51 4 329-334
LI Jian et al. The effects of preconditioning with pioglitazone on infarct size and mitochondrial ATP-sensitive potassium channel in rats with ischemia-reperfusion. (2009) ZHONGHUA JIZHEN YIXUE ZAZHI/CHINESE JOURNAL OF EMERGENCY MEDICINE 1671-0282 18 5 483-487
Bironaite D et al. Role of MAP kinases in nitric oxide induced muscle-derived adult stem cell apoptosis. (2009) CELL BIOLOGY INTERNATIONAL 1065-6995 1095-8355 33 7 711-719
Ryazantseva NV et al. Redox-dependent signal system in regulation of apoptosis under oxidative stress. (2009) CELL AND TISSUE BIOLOGY 1990-5203 3 4 311-316
Peng Tianqing et al. JNK1/c-fos inhibits cardiomyocyte TNF-alpha expression via a negative crosstalk with ERK and p38 MAPK in endotoxaemia. (2009) CARDIOVASCULAR RESEARCH 0008-6363 1755-3245 81 4 733-741
Liu Wei et al. Cardiac-Specific Deletion of Mkk4 Reveals Its Role in Pathological Hypertrophic Remodeling but Not in Physiological Cardiac Growth. (2009) CIRCULATION RESEARCH 0009-7330 1524-4571 104 7 905-U164
Rabkin Simon et al. The action of nitric oxide to enhance cell survival in chick cardiomyocytes is mediated through a cGMP and ERK1/2 pathway while p38 mitogen-activated protein kinase-dependent pathways do not alter cell death. (2008) EXPERIMENTAL PHYSIOLOGY 0958-0670 1469-445X 93 7 834-842
Wu Y-T et al. Signaling pathways from membrane lipid rafts to JNK1 activation in reactive nitrogen species-induced non-apoptotic cell death. (2008) CELL DEATH AND DIFFERENTIATION 1350-9047 1476-5403 15 2 386-397
Li Jian et al. Antiapoptosis and mitochondrial effect of pioglitazone preconditioning in the ischemic/reperfused heart of rat. (2008) CARDIOVASCULAR DRUGS AND THERAPY 0920-3206 1573-7241 22 4 283-291
Chai Weidong et al. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury. (2008) AMERICAN JOURNAL OF PHYSIOLOGY: ENDOCRINOLOGY AND METABOLISM 0193-1849 1522-1555 294 1 E183-E189
Winter-Vann Ann et al. Integrated activation of MAP3Ks balances cell fate in response to stress. (2007) JOURNAL OF CELLULAR BIOCHEMISTRY 0730-2312 1097-4644 102 4 848-858
Gautam P. Functions and significance of nitric oxide in patho-physiological processes. (2007) INDIAN JOURNAL OF BIOTECHNOLOGY 0972-5849 0975-0967 6 3 293-304
XIA Yong. Effects of celecoxib on cardiac myocyte apoptosis after myocardial infarction. (2007) CHINESE JOURNAL OF PATHOPHYSIOLOGY 1000-4718 23 1 49-52
Milano Giuseppina et al. A peptide inhibitor of c-Jun NH2-terminal kinase reduces myocardial ischemia-reperfusion injury and infarct size in vivo. (2007) AMERICAN JOURNAL OF PHYSIOLOGY: HEART AND CIRCULATORY PHYSIOLOGY 0363-6135 1522-1539 292 4 H1828-H1835
Fintha A et al. Angiotensin II activates plasminogen activator inhibitor-I promoter in renal tubular epithelial cells via the AT1 receptor. (2007) ACTA PHYSIOLOGICA HUNGARICA 0231-424X 1588-2683 2498-602X 94 1-2 19-30
Nishida Kazuhiko et al. The role of apoptosis signal-regulating kinase 1 in cardiomyocyte apoptosis. (2006) ANTIOXIDANTS & REDOX SIGNALING 1523-0864 1557-7716 8 9-10 1729-1736
Fan Guo-Chang et al. Small heat-shock protein Hsp20 attenuates beta-agonist-mediated cardiac remodeling through apoptosis signal-regulating kinase 1. (2006) CIRCULATION RESEARCH 0009-7330 1524-4571 99 11 1233-1242
Shen HM et al. JNK signaling pathway is a key modulator in cell death mediated by reactive oxygen and nitrogen species. (2006) FREE RADICAL BIOLOGY AND MEDICINE 0891-5849 1873-4596 40 6 928-939
Kawahara K et al. Ischemia/reperfusion-induced death of cardiac myocytes: possible involvement of nitric oxide in the coordination of ATP supply and demand during ischemia. (2006) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 40 1 35-46
Huh J et al. Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. (2006) CANCER RESEARCH 0008-5472 1538-7445 66 7 3726-3736
Shao ZL et al. c-jun N-terminal kinases mediate reactivation of Akt and cardiomyocyte survival after hypoxic injury in vitro and in vivo. (2006) CIRCULATION RESEARCH 0009-7330 1524-4571 98 1 111-118
Zebrowski David et al. Caspase-3 mediated cleavage of MEKK1 promotes p53 transcriptional activity. (2006) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 40 5 605-618
Schulz R et al. Recent advances in the understanding of the role of nitric oxide in cardiovascular homeostasis. (2005) PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X 108 3 225-256
Hsieh MH et al. Molecular mechanism of apoptosis induced by mechanical forces. (2005) INTERNATIONAL REVIEW OF CYTOLOGY-A SURVEY OF CELL BIOLOGY 0074-7696 1937-6448 245 45-90
Kim DS et al. Inhibitory effects of rosmarinic acid on adriamycin-induced apoptosis in H9c2 cardiac muscle cells by inhibiting reactive oxygen species and the activations of c-Jun N-terminal kinase and extracellular signal-regulated kinase. (2005) BIOCHEMICAL PHARMACOLOGY 0006-2952 1873-2968 70 7 1066-1078
Kaiser RA et al. Genetic inhibition or activation of JNK1/2 protects the myocardium from ischemia-reperfusion-induced cell death in vivo. (2005) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 280 38 32602-32608
Petrich BG et al. Targeted activation of c-Jun N-terminal kinase in vivo induces restrictive cardiomyopathy and conduction defects. (2004) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 279 15 15330-15338
Steinberg SF et al. Cardiovascular Signaling Pathways. (2004) Megjelent: Molecular Basis of Cardiovascular Disease: A Companion to Braunwald's Heart Disease pp. 123-174
Armstrong SC. Anti-oxidants and apoptosis: attenuation of doxorubicin induced cardiomyopathy by carvedilol. (2004) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 37 4 817-821
Terebessy T et al. Angiotensin II activates the human renin promoter in an in vitro model: the role of c-Jun-N-terminal Kinase. (2004) NEPHROLOGY DIALYSIS TRANSPLANTATION 0931-0509 1460-2385 19 9 2184-2191
Kang PM et al. Alterations in apoptosis regulatory factors during hypertrophy and heart failure. (2004) AMERICAN JOURNAL OF PHYSIOLOGY: HEART AND CIRCULATORY PHYSIOLOGY 0363-6135 1522-1539 287 1 H72-H80
McGowan B et al. The Balance Between Pro-Apoptotic and Anti-Apoptotic Pathways in the Failing Myocardium. (2003) CARDIOVASCULAR TOXICOLOGY 1530-7905 1559-0259 3 3 191-205
Zhang W et al. Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure. (2003) EXPERIMENTAL AND CLINICAL CARDIOLOGY 1205-6626 1918-1515 8 4 173-183
Maiese K et al. Nicotinamide: Necessary nutrient emerges as a novel cytoprotectant for the brain. (2003) TRENDS IN PHARMACOLOGICAL SCIENCES 0165-6147 24 5 228-232
Maiese K et al. Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain. (2003) TRENDS IN PHARMACOLOGICAL SCIENCES 0165-6147 24 5 228-232
Kwon SH et al. H2O2 regulates cardiac myocyte phenotype via concentration-dependent activation of distinct kinase pathways. (2003) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 35 6 615-621
Sun DS et al. Differential regulation of JNK in caspase-3-mediated apoptosis of MPP+-treated primary cortical neurons. (2003) CELL BIOLOGY INTERNATIONAL 1065-6995 1095-8355 27 9 769-777
Miller B et al. Cyclooxygenase 2 inhibits SAPK activation in neuronal apoptosis. (2003) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 300 4 884-888
Cicconi S et al. Characterization of apoptosis signal transduction pathways in HL-5 cardiomyocytes exposed to ischemia/reperfusion oxidative stress model. (2003) JOURNAL OF CELLULAR PHYSIOLOGY 0021-9541 1097-4652 195 1 27-37
Martire A et al. Cardiac overexpression of monocyte chemoattractant protein-1 in transgenic mice mimics ischemic preconditioning through SAPK/JNK1/2 activation. (2003) CARDIOVASCULAR RESEARCH 0008-6363 1755-3245 57 2 523-534
Kang PM et al. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases. (2003) TRENDS IN MOLECULAR MEDICINE 1471-4914 1471-499X 9 4 177-182
Sadoshima J et al. The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. (2002) JOURNAL OF CLINICAL INVESTIGATION 0021-9738 1558-8238 110 2 271-279
Curtin JF et al. Regulation and measurement of oxidative stress in apoptosis. (2002) JOURNAL OF IMMUNOLOGICAL METHODS 0022-1759 1872-7905 265 1-2 49-72
Valks DM et al. Phenylephrine promotes phosphorylation of bad in cardiac myocytes through the extracellular signal-regulated kinases 1/2 and protein kinase A. (2002) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 34 7 749-763
Kang PM et al. New insights into the role of apoptosis in cardiovascular disease. (2002) CIRCULATION JOURNAL: OFFICIAL JOURNAL OF THE JAPANESE CIRCULATION SOCIETY 1346-9843 1347-4820 66 1 1-9
Strniskova M et al. Mitogen-activated protein kinases and their role in regulation of cellular processes. (2002) GENERAL PHYSIOLOGY AND BIOPHYSICS 0231-5882 21 3 231-255
Aoki H et al. Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. (2002) JOURNAL OF BIOLOGICAL CHEMISTRY 0021-9258 1083-351X 277 12 10244-10250
Nobori K et al. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: A novel cardioprotective role of ATF3. (2002) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 34 10 1387-1397
Nobori K et al. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: A novel cardioprotective role of ATF3. (2002) JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY 0022-2828 1095-8584 34 10 1387-1397
Chen QM et al. Apoptosis and heart failure: Mechanisms and therapeutic implications. (2002) AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS 1175-3277 1179-187X 2 1 43-57
